De Novo KRAS G12C–Mutant SCLC: A Case Report
Authors:
Open Access
- 19 March 2022
- journal article
- research article
- Published by Elsevier in JTO Clinical and Research Reports
- Vol. 3 (5) , 100306
Abstract
No abstract availableKeywords
Funding Information
- National Comprehensive Cancer Network (030763)
This publication has 8 references indexed in Scilit:
- KRAS G12C Inhibition with Sotorasib in Advanced Solid TumorsNew England Journal of Medicine, 2020
- Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model dataNature Reviews Cancer, 2019
- Clinical validation of the tempus xT next-generation targeted oncology sequencing assayOncotarget, 2019
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung CancerNew England Journal of Medicine, 2018
- KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell CancerBalkan Medical Journal, 2016
- Comprehensive genomic profiles of small cell lung cancerNature, 2015
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancerNature Genetics, 2012
- Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse LungCancer Cell, 2011